117 related articles for article (PubMed ID: 22668812)
1. Upregulated expression of ADAM17 is a prognostic marker for patients with gastric cancer.
Shou ZX; Jin X; Zhao ZS
Ann Surg; 2012 Dec; 256(6):1014-22. PubMed ID: 22668812
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of ADAM17 in human gastric cancer.
Zhang TC; Zhu WG; Huang MD; Fan RH; Chen XF
Med Oncol; 2012 Dec; 29(4):2684-90. PubMed ID: 22139867
[TBL] [Abstract][Full Text] [Related]
3. ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.
Xu Q; Ying M; Chen G; Lin A; Xie Y; Ohara N; Zhou D
Tumour Biol; 2014 Aug; 35(8):7575-86. PubMed ID: 24793016
[TBL] [Abstract][Full Text] [Related]
4. ADAM17 promotes lymph node metastasis in gastric cancer via activation of the Notch and Wnt signaling pathways.
Li W; Wang D; Sun X; Zhang Y; Wang L; Suo J
Int J Mol Med; 2019 Feb; 43(2):914-926. PubMed ID: 30569104
[TBL] [Abstract][Full Text] [Related]
5. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between sphingosine kinase 1 expression and tumor invasion, metastasis and prognosis in gastric cancer].
Zhuge YH; Tao HQ; Wang YY
Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(39):2765-8. PubMed ID: 22322056
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study.
Shi H; Han J; Yue S; Zhang T; Zhu W; Zhang D
Biomed Pharmacother; 2015 Apr; 71():210-5. PubMed ID: 25960238
[TBL] [Abstract][Full Text] [Related]
9. SPARC is associated with gastric cancer progression and poor survival of patients.
Zhao ZS; Wang YY; Chu YQ; Ye ZY; Tao HQ
Clin Cancer Res; 2010 Jan; 16(1):260-8. PubMed ID: 20028745
[TBL] [Abstract][Full Text] [Related]
10. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Nedd9 is a prognostic marker of human gastric cancer.
Zhang Q; Wang H; Ma Y; Zhang J; He X; Ma J; Zhao ZS
Med Oncol; 2014 Jul; 31(7):33. PubMed ID: 24906654
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of ADAM17 for Gastric Cancer Survival: A Meta-Analysis.
Ni P; Yu M; Zhang R; He M; Wang H; Chen S; Duan G
Medicina (Kaunas); 2020 Jun; 56(7):. PubMed ID: 32610677
[No Abstract] [Full Text] [Related]
13. High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters.
Hakuma N; Betsuyaku T; Kinoshita I; Itoh T; Kaga K; Kondo S; Nishimura M; Dosaka-Akita H
Oncology; 2007; 72(3-4):197-204. PubMed ID: 18160808
[TBL] [Abstract][Full Text] [Related]
14. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
[TBL] [Abstract][Full Text] [Related]
15. High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer.
Stenzinger A; Wittschieber D; von Winterfeld M; Goeppert B; Kamphues C; Weichert W; Dietel M; Rabien A; Klauschen F
Hum Pathol; 2012 Sep; 43(9):1471-81. PubMed ID: 22417846
[TBL] [Abstract][Full Text] [Related]
16. Protein expression of osteopontin in tumor tissues is an independent prognostic indicator in gastric cancer.
Dai N; Bao Q; Lu A; Li J
Oncology; 2007; 72(1-2):89-96. PubMed ID: 18004082
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
[TBL] [Abstract][Full Text] [Related]
18. A novel marker ADAM17 for clear cell renal cell carcinomas: implication for patients' prognosis.
Li G; Forest F; Feng G; Gentil-Perret A; Péoc'h M; Cottier M; Mottet N
Urol Oncol; 2014 Nov; 32(8):1272-6. PubMed ID: 24996774
[TBL] [Abstract][Full Text] [Related]
19. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer.
Bi J; Lau SH; Lv ZL; Xie D; Li W; Lai YR; Zhong JM; Wu HQ; Su Q; He YL; Zhan WH; Wen JM; Guan XY
Hum Pathol; 2009 Dec; 40(12):1790-7. PubMed ID: 19765801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
